FDA NDC Directory · JSON-LD · Markdown

liraglutide

NDC 81607-019 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerOrbicular Pharmaceutical Technologies Private Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA217234
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsLIRAGLUTIDE (6 mg/mL)
Marketing started20260226
Package count2

External sources

Source: openFDA. Public-domain (CC0).